AU7270600A - Bivalent inhibitor of fviia/tf/fxa complex - Google Patents
Bivalent inhibitor of fviia/tf/fxa complexInfo
- Publication number
- AU7270600A AU7270600A AU72706/00A AU7270600A AU7270600A AU 7270600 A AU7270600 A AU 7270600A AU 72706/00 A AU72706/00 A AU 72706/00A AU 7270600 A AU7270600 A AU 7270600A AU 7270600 A AU7270600 A AU 7270600A
- Authority
- AU
- Australia
- Prior art keywords
- fviia
- fxa complex
- bivalent inhibitor
- bivalent
- inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA199901333 | 1999-09-20 | ||
| DKPA199901333 | 1999-09-20 | ||
| US15977399P | 1999-10-15 | 1999-10-15 | |
| US60159773 | 1999-10-15 | ||
| PCT/DK2000/000516 WO2001021661A1 (en) | 1999-09-20 | 2000-09-19 | BIVALENT INHIBITOR OF FVIIa/TF/FXa COMPLEX |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU7270600A true AU7270600A (en) | 2001-04-24 |
Family
ID=26065599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU72706/00A Abandoned AU7270600A (en) | 1999-09-20 | 2000-09-19 | Bivalent inhibitor of fviia/tf/fxa complex |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU7270600A (en) |
| WO (1) | WO2001021661A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1485476A2 (en) * | 2002-03-12 | 2004-12-15 | Novo Nordisk A/S | Dimeric tf antagonist |
| AU2003242507A1 (en) * | 2002-07-12 | 2004-02-02 | Novo Nordisk A/S | A tissue factor binding immunoconjugate comprising factor viia |
| AU2003242506A1 (en) * | 2002-07-12 | 2004-02-02 | Novo Nordisk A/S | Tf antagonist |
| US7638513B2 (en) | 2004-06-02 | 2009-12-29 | Schering Corporation | Compounds for the treatment of inflammatory disorders |
| PE20060426A1 (en) * | 2004-06-02 | 2006-06-28 | Schering Corp | TARTARIC ACID DERIVATIVES AS INHIBITORS OF MMPs, ADAMs, TACE AND TNF-alpha |
| JP5290753B2 (en) * | 2005-06-17 | 2013-09-18 | ノボ ノルディスク ヘルス ケア アーゲー | Dimeric and multimeric FVIIa compounds |
| AU2017206445B2 (en) | 2016-01-15 | 2019-07-18 | Rigshospitalet | Quantitative pet imaging of tissue factor expression using 18F-labled active site inhibited factor VII |
| WO2018091058A1 (en) | 2016-11-17 | 2018-05-24 | Rigshospitalet | 177-lu labeled active site inhibited factor vii |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5106833A (en) * | 1987-07-23 | 1992-04-21 | Washington University | Coagulation inhibitors |
| US5242810A (en) * | 1990-12-07 | 1993-09-07 | Biogen, Inc. | Bifunctional inhibitors of thrombin and platelet activation |
| WO1999061055A1 (en) * | 1998-05-22 | 1999-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
-
2000
- 2000-09-19 WO PCT/DK2000/000516 patent/WO2001021661A1/en not_active Ceased
- 2000-09-19 AU AU72706/00A patent/AU7270600A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001021661A1 (en) | 2001-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5062100A (en) | Fviia/tf activity inhibiting compounds | |
| AU2001241078A1 (en) | Alpha-amylase activity inhibitors | |
| AU4107801A (en) | Alpha-amylase activity inhibitors | |
| AU2001266068A1 (en) | Treatment of mineral substrates | |
| AU2001234689A1 (en) | Bivalent phenylene inhibitors of factor xa | |
| AU6111000A (en) | Inhibitors of viral helcase | |
| AU2001285750A1 (en) | Urokinase inhibitors | |
| IL135466A0 (en) | Enzymatic modification of sterols | |
| AU2001236052A1 (en) | Urease inhibitors | |
| IL145772A0 (en) | Prodrugs of thrombin inhibitors | |
| AU7270600A (en) | Bivalent inhibitor of fviia/tf/fxa complex | |
| PL352200A1 (en) | Inhibitors of viia agent | |
| AU2002219175A1 (en) | Crystalline forms of cerivastatin sodium | |
| AU2002338734A1 (en) | Use of phosphorodiesterase IV inhibitors | |
| GB0030284D0 (en) | Enzyme inhibitors | |
| GB9924522D0 (en) | Enzyme inhibitors | |
| AU2002222933A1 (en) | Inhibitors of factor xa | |
| AU3729300A (en) | Brain-associated inhibitor of tissue-type plasminogen activator | |
| AU8005100A (en) | Inhibitors of neuraminidases | |
| EP1467978A4 (en) | Pancreatic lipase inhibitor compounds, their synthesis and use | |
| AU7323000A (en) | Conditional inhibition of vegetative propagation | |
| IL151921A0 (en) | Liphopilic diesters of chelating agent for inhibition of enzyme activity | |
| AU2002305868A1 (en) | Inhibitors of reggamma | |
| GB0100151D0 (en) | Methods of sputtering | |
| GB0109278D0 (en) | Enzyme inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |